Home > Boards > US Listed > Cannabis > GW Pharmaceuticals Plc ADS (GWPH)

What created the decline in rev from 2014

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BrazenBull Member Profile
 
Followed By 125
Posts 8,109
Boards Moderated 4
Alias Born 11/14/12
160x600 placeholder
Leveraging Cannabinoids in Pediatric Medicine InvestorsHub NewsWire - 8/12/2019 12:08:05 PM
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019 GlobeNewswire Inc. - 8/6/2019 4:01:00 PM
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures ... GlobeNewswire Inc. - 7/26/2019 6:37:16 AM
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending June 30, 2019 and Host Conf... GlobeNewswire Inc. - 7/23/2019 1:27:34 PM
With 10,000 Licenses Issued, California Reflects the Growing Power of Hemp NetworkNewsWire - 7/16/2019 8:45:00 AM
Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer GlobeNewswire Inc. - 6/27/2019 8:00:00 AM
Acquisitions, Licenses, Research Key in Consistent Cannabis Market Growth NetworkNewsWire - 6/20/2019 8:45:00 AM
Dramatically Improved Delivery Systems Promise More Effective Cannabis Treatments NetworkNewsWire - 6/11/2019 8:45:00 AM
GW Pharmaceuticals to Present at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11th, 2019 GlobeNewswire Inc. - 6/4/2019 6:42:11 AM
Disruptive CBD Delivery Technology Could Revolutionize World of Cannabis Consumer Products, Edibles NetworkNewsWire - 5/29/2019 8:45:00 AM
CBD Stocks on the Rise InvestorsHub NewsWire - 5/28/2019 10:30:32 AM
AI and Cannabis Could Make Investors Happy InvestorsHub NewsWire - 5/23/2019 9:00:00 AM
CBD Medical Plays to Watch InvestorsHub NewsWire - 5/22/2019 11:25:00 AM
Cannabis Producers Look to Differentiate-THC Therapeutics, Inc. (THCT) InvestorsHub NewsWire - 5/21/2019 10:30:00 AM
GW Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference on Wednesday, May 15, 2019 GlobeNewswire Inc. - 5/9/2019 8:35:58 AM
Surging Vape Market Propels Smart Brands Growth NetworkNewsWire - 5/8/2019 8:45:00 AM
GW Pharmaceuticals Reports Positive Phase 3 Pivotal Trial Results for EPIDIOLEX® (cannabidiol) Oral Solution in Patients wit... GlobeNewswire Inc. - 5/6/2019 4:01:00 PM
GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2019 GlobeNewswire Inc. - 5/6/2019 4:01:00 PM
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol) oral solution, CV a... GlobeNewswire Inc. - 5/2/2019 7:00:00 AM
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Con... GlobeNewswire Inc. - 4/23/2019 1:40:38 PM
GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Appointment of Darren Cline as U.S. Chief Commercia... GlobeNewswire Inc. - 4/11/2019 4:05:00 PM
CBD Industry Set to Explode as New Products, Consumers Enter Market NetworkNewsWire - 4/3/2019 8:45:00 AM
GW Pharmaceuticals plc Announces the Sale of Priority Review Voucher for $105M GlobeNewswire Inc. - 3/18/2019 7:30:00 AM
Cannabis Has Record-Setting Month InvestorsHub NewsWire - 3/5/2019 8:30:00 AM
Cannabis Stocks Crushing Short Sellers InvestorsHub NewsWire - 2/28/2019 9:00:00 AM
BrazenBull   Thursday, 08/02/18 03:34:29 AM
Re: doughboy2 post# 5160
Post # of 5533 
What created the decline in rev from 2014 to 2017?


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist